Apollo Therapeutics: Valuation, Funding & Investors
https://www.apollotherapeutics.com/Research Platforms
Apollo Therapeutics is a drug discovery and development company that partners with academic institutions and industry to translate early-stage scientific discoveries into therapeutic candidates. The company coordinates target validation, medicinal chemistry, and preclinical development capabilities to advance programs toward clinical development.
Leadership & Board
- Current Number of Employees
- 66
- Current LinkedIn Followers
- 10,667
Latest Estimated Valuation
- Total Amount Raised
- $34M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $34M
- Latest Funding Round
- Series C
Employee Trend
Apollo Therapeutics had 66 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
66Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Apollo Therapeutics had 10,667 followers as of October 26, 2026. The number of followers increased by 61 (0.58%) week-over-week.
10,667Latest Followers Count
61(0.58%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 02, 2024 | Series C | $33.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Patient Square Capital | Series C |
Similar Companies
A snapshot of private companies similar to Apollo Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
